ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Jasper Therapeutics Inc

Jasper Therapeutics Inc (JSPR)

5,51
0,17
(3,18%)
Geschlossen 20 Januar 10:00PM
5,667
0,157
(2,85%)
Nach Börsenschluss: 1:59AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
5,667
Gebot
5,55
Fragen
5,89
Volumen
722.122
5,25 Tagesbereich 5,89
5,34 52-Wochen-Bereich 31,01
Marktkapitalisierung
Handelsende
5,34
Handelsbeginn
5,40
Letzter Handelszeitpunkt
Finanzvolumen
US$ 4.050.102
VWAP
5,6086
Durchschnittliches Volumen (3 Mio.)
438.640
Ausgegebene Aktien
15.001.353
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,28
Gewinn pro Aktie (EPS)
-4,3
Erlöse
-
Nettogewinn
-64,47M

Über Jasper Therapeutics Inc

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem ce... Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Jasper Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker JSPR. The last closing price for Jasper Therapeutics was US$5,34. Over the last year, Jasper Therapeutics shares have traded in a share price range of US$ 5,34 to US$ 31,01.

Jasper Therapeutics currently has 15.001.353 shares in issue. The market capitalisation of Jasper Therapeutics is US$80,11 million. Jasper Therapeutics has a price to earnings ratio (PE ratio) of -1.28.

JSPR Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.453-20.40730337087.127.295.3412675396.38045834CS
4-15.483-73.205673758921.1522.9855.349554419.50762858CS
12-14.293-71.608216432919.9626.055.3443864013.79958428CS
26-15.933-73.763888888921.626.055.3433036716.01124225CS
52-3.283-36.68156424588.9531.015.3423153617.51463037CS
156-52.133-90.195501730157.858.13.86255187917.79935043CS
260-134.933-95.9694167852140.6188.83.86270671853.3112587CS

JSPR - Frequently Asked Questions (FAQ)

What is the current Jasper Therapeutics share price?
The current share price of Jasper Therapeutics is US$ 5,667
How many Jasper Therapeutics shares are in issue?
Jasper Therapeutics has 15.001.353 shares in issue
What is the market cap of Jasper Therapeutics?
The market capitalisation of Jasper Therapeutics is USD 80,11M
What is the 1 year trading range for Jasper Therapeutics share price?
Jasper Therapeutics has traded in the range of US$ 5,34 to US$ 31,01 during the past year
What is the PE ratio of Jasper Therapeutics?
The price to earnings ratio of Jasper Therapeutics is -1,28
What is the reporting currency for Jasper Therapeutics?
Jasper Therapeutics reports financial results in USD
What is the latest annual profit for Jasper Therapeutics?
The latest annual profit of Jasper Therapeutics is USD -64,47M
What is the registered address of Jasper Therapeutics?
The registered address for Jasper Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Jasper Therapeutics website address?
The website address for Jasper Therapeutics is www.jaspertherapeutics.com
Which industry sector does Jasper Therapeutics operate in?
Jasper Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock